Skip to main content
SpringerLink
Log in

Pathology of Pituitary Adenomas and Pituitary Hyperplasia

  • Chapter
Diagnosis and Management of Pituitary Tumors

  • 269 Accesses

Abstract

Of the diverse neoplasms affecting the sellar region, pituitary adenomas are by far the most common. Their pathologic features are the substance of the present chapter, which is limited to a discussion of benign tumors. The same is true of invasive adenomas and pituitary carcinoma. Discussions of their epidemiology, molecular genetics, endocrine, radiologic, as well as therapeutic aspects are the subjects of separate chapters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kovacs K, Scheithauer BW, Horvath E, Lloyd RV. The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme. Cancer 1996;78:502–510.

    PubMed  CAS  Google Scholar 

  2. Kovacs K, Scheithauer BW, Horvath E, Lloyd RV. The adenohy-pophysis. In: Solcia E, Kloppel G, Sobin LH, eds. The World Health Organization Classification of Endocrine Tumours, 2nd ed. Springer-Verlag, Berlin, 1999, pp. 15–28, 75–90.

    Google Scholar 

  3. Kovacs K, Horvath E. Tumors of the pituitary gland. Atlas of tumor pathology, 2nd Ser. Fasc. 21. Armed Forces Institute of Pathology, Washington, DC, 1986, pp. 1–264.

    Google Scholar 

  4. Sheenhan DC, Hropchak BB. Theory and Practice of Histochemistry. CV Mosby, St. Louis, 1980, pp. 276–279.

    Google Scholar 

  5. Smith DM Jr, Haggitt RC. A comparative study of generic stains for carcinoid secretory granules. Am J Surg Pathol 1983;7:61–68.

    PubMed  Google Scholar 

  6. Pearse AGE. The APUD concept and its implications in pathology. Pathol Annu 1974;9:27–41.

    PubMed  CAS  Google Scholar 

  7. Thapar K, Yamada Y, Scheithauer B, Kovacs K, Yamada S, Stefaneanu L. Assessment of mitotic activity in pituitary adenomas and carcinomas. Endocr Pathol 1996;7:215–221.

    PubMed  Google Scholar 

  8. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, et al. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 1996;38:99–106.

    PubMed  CAS  Google Scholar 

  9. Hsu DW, Hakim F, Biller BMK, de la Monte S, Zervas NT, Klibanski A, et al. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 1993;78:753–761.

    PubMed  CAS  Google Scholar 

  10. Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, et al. p53 protein accumulates in Cushing’s adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab 1994;79:1513–1516.

    PubMed  CAS  Google Scholar 

  11. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 1996;38:763–771.

    Google Scholar 

  12. Coons AH, Creech HJ, Jones RN. Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med 1941;47:200–202.

    CAS  Google Scholar 

  13. Sternberger LA, Hardy PH Jr., Cuculis JJ, Meyer HG. The unlabeled antibody enzyme method to immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem 1970; 18: 315–333.

    PubMed  CAS  Google Scholar 

  14. Taylor CR. Immunoperoxidase techniques. Practical and theoretical aspects. Arch Pathol Lab Med 1978;102:113–121.

    PubMed  CAS  Google Scholar 

  15. Childs GV, Unabia G. Application of avidin-biotin-peroxi-dase complex (ABC) method to the light microscopic localization of pituitary hormones. J Histochem Cytochem 1982; 30:713–716.

    PubMed  CAS  Google Scholar 

  16. Gosselin EJ, Cate CC, Pettengill OS, Sorenson GD. Immunocy-tochemistry: its evolution and criteria for its application in the study of epon-embedded cells and tissues. Am J Anat 1986; 175:135–160.

    PubMed  CAS  Google Scholar 

  17. Sternberger L. Immunocytochemistry, 3rd ed. John Wiley, New York, 1986.

    Google Scholar 

  18. Nakane PK, Pierce GB Jr. Enzyme-labelled antibodies: preparation and application for localization of antigen. J Histochem Cytochem 1966;14:929–931.

    PubMed  CAS  Google Scholar 

  19. Hsu SM, Raine L, Fanger H. A comparative study of the peroxi-dase-antiperoxidase method and avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981;75:734–738.

    PubMed  CAS  Google Scholar 

  20. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577–580.

    PubMed  CAS  Google Scholar 

  21. Taylor CR. Immunomicroscopy: A Diagnostic Tool for the Surgical Pathologist. WB Saunders, Philadelphia, 1986.

    Google Scholar 

  22. Mayers CP. Histological fixation by microwave heating. J Clin Pathol 1970;23:273–275.

    PubMed  CAS  Google Scholar 

  23. Leong ASY, Dayman ME, Milos J. Microwave irradiation as a form of fixation for light and electron microscopy. J Pathol 1985;146:313–321.

    PubMed  CAS  Google Scholar 

  24. Boon ME, Kok LP. Microwave Cookbook of Pathology. The Art of Microscopic Visualization, 2nd ed. Coubomb, Leyder, 1988.

    Google Scholar 

  25. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed paraffin-embedded tissues: an enhancement method for immuno-histochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741–748.

    PubMed  CAS  Google Scholar 

  26. Leong ASY. Microwave technology for morphological analysis. Cell Vision 1994;1:278–288.

    Google Scholar 

  27. Bourinbaiar AS. Microwave irradiation-stimulated in situ hybridization procedure with biotinylated DNA probe. Eur J Morphol 1991;29:213–128.

    PubMed  CAS  Google Scholar 

  28. Volkers HH, van den Brink WJ, Rook R, van den Berg FM. Micro wave label detection technique for DNA in situ hybridization. Eur J Morphol 1991;29:59–62.

    PubMed  CAS  Google Scholar 

  29. Allan GM, Smyth JA, Todd D, McNulty MS. In situ hybridization for the detection of chicken anemia virus in formalin-fixed paraffin-embedded section. Avian Dis 1993;37:177–182.

    PubMed  CAS  Google Scholar 

  30. Evers P, Vylings HBM. Microwave-stimulated antigen retrieval is pH and temperature dependent. J Histochem Cytochem 1994; 42:1555–1563.

    PubMed  CAS  Google Scholar 

  31. Sperry A, Jin L, Lloyd RV. Microwave treatment enhances detection of RNA and DNA by in situ hybridization. Diagn Mol Pathol 1996;5:291–296.

    PubMed  CAS  Google Scholar 

  32. Kovacs K, Horvath E. Pathology of growth-hormone-producing tumors of the human pituitary. Semin Diagn Pathol 1986;3:18–33.

    PubMed  CAS  Google Scholar 

  33. Horvath E. Ultrastructural markers in the pathologic diagnosis of pituitary adenomas. Ultrastruct Pathol 1994;18:171–179.

    PubMed  CAS  Google Scholar 

  34. Horvath E, Scheithauer BW, Kovacs K, Lloyd RV. Regional neuropathology: hypothalamus and pituitary. In: Graham DI, Lantos PL, eds. Greenfield’s Neuropathology, 6th ed., Arnold, London, 1997, pp. 1007–1094.

    Google Scholar 

  35. Tindall GT, Kovacs K, Horvath E, Thorner MO. Human prolactin-producing adenomas and bromocriptine: a histological, immuno-cytochemical, ultrastructural and morphometric study. J Clin Endocrinol Metab 1982;55:1178–1183.

    PubMed  CAS  Google Scholar 

  36. Kovacs K, Stefaneanu L, Horvath E, Lloyd RV, Lancranjan I, Buchfelder M, et al. Effect of dopamine agonist medication on prolactin producing pituitary adenomas. A morphologic study including immunocytochemistry, electron microscopy and in situ hybridization. Virchows Arch Pathol Anat 1991;418:439–446.

    CAS  Google Scholar 

  37. Tougard C, Picart R. Use of pre-embedding ultrastructural immunocytochemistry in the localization of a secretory product and membrane proteins in cultured prolactin cells. Am J Anat 1986; 175:161–177.

    PubMed  CAS  Google Scholar 

  38. Frawley LS, Neill JD. A reverse hemolytic plaque assay for microscopic visualization of growth hormone release from individual cells: evidence for somatotrope heterogeneity. Neuroendocrinol-ogy 1984;39:484–487.

    CAS  Google Scholar 

  39. Childs GV, Burke JA. Use of the reverse hemolytic plaque assay to study the regulation of anterior lobe adrenocorticotropin (ACTH) secretion by ACTH-releasing factor, arginine vasopressin, angiotensin II and glucocorticoids. Endocrinology 1987;120:439–444.

    PubMed  CAS  Google Scholar 

  40. Lloyd RV, Coleman K, Fields K, Nath V. Analysis of prolactin and growth hormone production in hyperplastic and neoplastic rat pituitary tissue by the hemolytic plaque assay. Cancer Res 1987;47:1087–1092.

    PubMed  CAS  Google Scholar 

  41. Lloyd RV, Anagnostou D, Cano M, Barkan AL, Chandler WF. Analysis of mammosomatotropic cells in normal and neoplastic human pituitary tissue by the reverse hemolytic plaque assay and immunocytochemistry. J Clin Endocrinol Metab 1988;66: 1103–1110.

    PubMed  CAS  Google Scholar 

  42. Kendall ME, Hymer WC. Measurement of hormone secretion from individual cells by cell blot assay. Methods Enzymol 1989; 168:327–338.

    PubMed  CAS  Google Scholar 

  43. Vila-Porcile E, Picart R, Tougard C. Adaptation of the reverse hemolytic plaque assay to electron microscopy: a study of one individual secretory activity in prolactin cell subpopulations. J Histochem Cytochem 1994;42:11–22.

    PubMed  CAS  Google Scholar 

  44. Alvaro V, Levy L, Dubray C, Roche A, Peillon F, Querat B, et al. Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. J Clin Endocrinol Metab 1993;77:1125–1129.

    PubMed  CAS  Google Scholar 

  45. Thakkar RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 1993;91:2815–2821.

    Google Scholar 

  46. Lloyd RV, Jin L, Chandler WF, Horvath E, Stefaneanu L, Kovacs K. Pituitary specific transcription factor messenger ribonucleic acid expression in adenomatous and nontumorous human pituitary tissues. Lab Invest 1994;69:570–575.

    Google Scholar 

  47. Cowan JM. Fishing for chromosomes. The art and its applications. Diagn Mol Pathol 1996;3:224–226.

    Google Scholar 

  48. Kontogeorgos G, Kapranos N. Interphase analysis of chromosome II in human pituitary somatotroph adenomas by direct fluorescence in situ hybridization. Endocr Pathol 1996;7:203–206.

    PubMed  Google Scholar 

  49. Templeton NS. The polymerase chain reaction. History, methods, and applications. Diagn Mol Pathol 1992;1:58–72.

    PubMed  CAS  Google Scholar 

  50. Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez-Manchon C, et al. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 1992; 131:2083–2089.

    PubMed  CAS  Google Scholar 

  51. Stefaneanu L, Kovacs K. Transgenic models of pituitary disease. Microsc Res Tech 1997;39:194–204.

    PubMed  CAS  Google Scholar 

  52. Harvey M, Vogel H, Eva YH, Lee P, Bradley A, Donehower LA. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 1995;55:1146–1151.

    PubMed  CAS  Google Scholar 

  53. Lloyd RV, Wilson BS, Kovacs K, Ryan N. Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas. Arch Pathol Lab Med 1985;109:515–517.

    PubMed  CAS  Google Scholar 

  54. Lloyd RV, Cano M, Rosa P, Hille A, Huttner WB. Distribution of chromogranin A and secretogranin I (chromogranin B) in neuroendocrine cells and tumors. Am J Pathol 1988;130:296–304.

    PubMed  CAS  Google Scholar 

  55. Jin L, Hemperly JJ, Lloyd RV. Expression of neural cell adhesion molecule (N-CAM) in normal and neoplastic human neuroendocrine tissues. Am J Pathol 1991;138:961–969.

    PubMed  CAS  Google Scholar 

  56. Stefaneanu L, Ryan N, Kovacs K. Immunocytochemical localization of synaptophysin in human hypophyses and pituitary adenomas. Arch Pathol Lab Med 1988;112:801–804.

    PubMed  CAS  Google Scholar 

  57. Asa SL, Ryan N, Kovacs K, Singer W, Marangos PJ. Immunohistochemical localization of neuron-specific enolase in the human hypophysis and pituitary adenomas. Arch Pathol Lab Med 1984;108:40–43.

    PubMed  CAS  Google Scholar 

  58. Lloyd RV, Jin L, Qian X, Scheithauer BW, Young WF Sr., Daus DH. Analysis of the chromogranin. A post-translational cleavage product pancreastatin and the prohormone convertase PC2 and PC3 in hormonal and neoplastic human pituitaries. Am J Pathol 1995;146:1188–1199.

    PubMed  CAS  Google Scholar 

  59. Marin F, Kovacs K, Stefaneanu L, Horvath E, Cheng Z. S-100 protein immunopositivity in human nontumorous hypophyses and pituitary adenomas. Endocr Pathol 1992;3:28–38.

    Google Scholar 

  60. Vrontakis ME, Sano T, Kovacs K, Friesen HG. Presence of galanin-like immunoreactivity in non-tumorous corticotrophs and corticotroph adenomas of the human pituitary. J Clin Endocrinol Metab 1987;66:804–810.

    Google Scholar 

  61. Ironside JW, Royds JA, Jefferson AA, Timperley WR. Immu-nolocalization of cytokeratins in the normal and neoplastic human pituitary gland. J Neurol Neurosurg Psychiatry 1987;50:57–65.

    PubMed  CAS  Google Scholar 

  62. Rehfeld JF, Lindholm J, Andersen BN, Bardram L, Canter P, Fenger M, et al. Pituitary tumors containing cholecystokinin. N Engl J Med 1987;316:1244–1247.

    PubMed  CAS  Google Scholar 

  63. Mizuno K, Ojima M, Hashimoto S, Watari H, Tani M, Satoh M, et al. Multiple forms of immunoreactive renin in human pituitary tissue. Life Sci 1985;37:2297–2304.

    PubMed  CAS  Google Scholar 

  64. Saint-Andre JP, Rohmer V, Alhenc-Gelas F, Menard J, Bigorgne J-C, Corvol P. Presence of renin, angiotensinogen and converting enzyme in human pituitary lactotroph cells and prolactin adenomas. J Clin Endocrinol Metab 1986;63:231–237.

    PubMed  CAS  Google Scholar 

  65. Deftos LJ. Pituitary cells secrete calcitonin in the reverse hemolytic plaque assay. Biochem Biophys Res Commun 1987;146: 1350–1356.

    PubMed  CAS  Google Scholar 

  66. Roth KA, Krause JE. Substance-P is present in a subset of thyrotrophs in the human pituitary. J Clin Endocrinol Metab 1990;71:1089–1095.

    PubMed  CAS  Google Scholar 

  67. Hsu DW, Riskind PN, Hedley-Whyte TE. Vasoactive intestinal peptide in the human pituitary gland and adenomas. An immunocytochemical study. Am J Pathol 1989;135:329–338.

    PubMed  CAS  Google Scholar 

  68. Le Dafniet M, Grouselle D, Li JY, Kujas M, Bression D, Barret A, et al. Evidence of thyrotropin-releasing hormone (TRH) and TRH-binding sites in human nonsecreting pituitary adenomas. J Clin Endocrinol Metab 1987;65:1014–1019.

    PubMed  Google Scholar 

  69. Rauch C, Li JY, Croissandeau G, Berthet M, Peillon F, Pages P. Characterization and localization of an immunoreactive growth hormone-releasing hormone precursor form in normal and tumoral human anterior pituitaries. Endocrinology 1995;136:2594–2601.

    PubMed  CAS  Google Scholar 

  70. Miller GM, Alexander JM, Klibanoki A. Gonadotropin-releasing hormone messenger RNA expression in gonadotroph tumors and normal human pituitary. J Clin Endocrinol Metab 1996;81:80–83.

    PubMed  CAS  Google Scholar 

  71. Odell WD, Griffin J, Bashey HM, Snyder PJ. Secretion of chorionic gonadotropin by cultured human pituitary cells. J Clin Endocrinol Metab 1990;71:1318–1321.

    PubMed  CAS  Google Scholar 

  72. Johnson MD, Gray ME, Pepinsky RB, Stahlman MT. Lipocortin-1 immunoreactivity in the human pituitary gland. J Histochem Cytochem 1990;38:1841–1845.

    PubMed  CAS  Google Scholar 

  73. Kovacs K, Ryan N, Stefaneanu L. Identification of corticotrophs in the human pituitary with mAB lu-5, a novel immunocytochemi-cal marker. Pathol Res Pract 1987;182:775–779.

    PubMed  CAS  Google Scholar 

  74. Silverlight JJ, Prysor-Jones RA, Jenkins JS. Basic fibroblast growth factor in human pituitary tumours. Clin Endocrinol 1990;32:669–676.

    CAS  Google Scholar 

  75. Kobrin MS, Asa SL, Samsoondar J, Kudlow JE. α-transforming growth factor in the bovine anterior pituitary gland: secretion by dispersed cells and immunohistochemical localization. Endocrinology 1987;121:1412–1416.

    PubMed  CAS  Google Scholar 

  76. Jin L, Qian X, Kulig E, Sanno N, Scheithauer BW, Kovacs K, et al. Transforming growth factor-p, transforming growth factor beta receptor II and p27Kipl expression in nontumorous and neoplastic human pituitaries. Am J Pathol 1997;151:509–519.

    PubMed  CAS  Google Scholar 

  77. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989;161:851–858.

    PubMed  CAS  Google Scholar 

  78. Alberti VN, Takita LC, de Mesquita MI, Percario S, Maciel RM. Immunohistochemical demonstration of insulin-like growth factor I (IGF-I) in normal and pathological human pituitary gland. Pathol Res Pract 1991;187:541–542.

    PubMed  CAS  Google Scholar 

  79. Budd GC, Pansky B, Budd NJ. Insulin or insulin-like peptides in the human pituitary. Ann Clin Lab Sci 1987;17:111–115.

    PubMed  CAS  Google Scholar 

  80. Scheithauer BW, Kovacs K, Horvath E. The adenohypophysis. In: Lechago J, Gould VE, eds. Bloodworth’s Endocrine Pathology, 3rd ed. 1997, Williams and Wilkins, Baltimore, MD, pp. 85–152.

    Google Scholar 

  81. Horvath E, Kovacs K. The adenohypophysis. In: Kovacs K, Asa SL, eds. Functional Endocrine Pathology, 2nd Edition, Blackwell, Boston, 1998, pp. 247–281.

    Google Scholar 

  82. Horvath E, Kovacs K. Fine structural cytology of the adenohypophysis in rat and man. J Electron Microsc Tech 1988;8:401–432.

    PubMed  CAS  Google Scholar 

  83. Lloyd RV. Analysis of mammosomatotropic cells in normal and neoplastic human pituitaries. Pathol Res Pract 1988; 183:577–579.

    PubMed  CAS  Google Scholar 

  84. Scheithauer BW, Sano T, Kovacs K, Young WR Jr, Ryan N, Randall RV. The pituitary gland in pregnancy, a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990;65:461–474.

    PubMed  CAS  Google Scholar 

  85. Allaerts W, Carmeliet T, Denef C. New perspectives in the function of pituitary folliculo-stellate cells. Mol Cell Endo 1990;71:73–81.

    CAS  Google Scholar 

  86. Marin F, Stefaneanu L, Kovacs K. Folliculo-stellate cells in the pituitary. Endocr Pathol 1991;2; 180–192.

    Google Scholar 

  87. McGrath P. Cysts of sellar and pharyngeal hypophyses. Pathology 1971;3:123–131.

    PubMed  CAS  Google Scholar 

  88. Asa SL, Kovacs K, Bilbao JM. The pars tuberalis of the human pituitary. A histologic, immunohistochemical, ultrastructural and immunoelectron microscopic analysis. Virchow Arch A, Pathol Anat Histopathol 1983;399:49–59.

    CAS  Google Scholar 

  89. Schochet SS Jr, McCormick WF, Helmi NS. Salivary gland rests in the human pituitary. Light and electron microscopic study. Arch Pathol 1974;98:193–200.

    PubMed  Google Scholar 

  90. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990;71: 1427–1433.

    PubMed  CAS  Google Scholar 

  91. Jacoby LB, Hedley-Whyte ET, Pulaski K, Seizinger BR, Martuza RL. Clonal origin of pituitary adenomas. J Neurosurg 1990; 73:731–735.

    PubMed  CAS  Google Scholar 

  92. Schulte HM, Oldfield EH, Allolio B, Katz DA, Berkman RA, Ali IU. Clonal composition of pituitary adenomas in patients with Cushing’s disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab 1991;73:1302–1308.

    PubMed  CAS  Google Scholar 

  93. Biller BM, Alexander JM, Zervas NT, Hedley-Whyte ET, Arnold A, Klibanski A. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing’s disease. J Clin Endocrinol Metab 1992;75:1303–1309.

    PubMed  CAS  Google Scholar 

  94. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL. Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 1992;74:914–919.

    PubMed  CAS  Google Scholar 

  95. Cyrns VL, Alexander JM, Klibanski A, Arnold A. The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab 1993;77:644–646.

    Google Scholar 

  96. Herman V, Drazin NZ, Gonsky R, Melmed S. Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 1993;77:50–55.

    PubMed  CAS  Google Scholar 

  97. Lloyd RV. Molecular biological analysis of pituitary disorders. In: Lloyd RV, ed. Surgical Pathology of the Pituitary Gland. WB Saunders, Philadelphia, 1993, pp, 85–93.

    Google Scholar 

  98. Boggild MD, Jenkinson S, Pistorello M, Boscaro M, Scanarini M, McTernan P, et al. Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab 1994;78:387–392.

    PubMed  CAS  Google Scholar 

  99. Scheithauer BW, Laws ER Jr, Kovacs K, Horvath E, Randall RV, Carney JA. Pituitary adenomas of the multiple endocrine neoplasia type I syndrome. Semin Diagn Pathol 1987;4:205–211.

    PubMed  CAS  Google Scholar 

  100. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: A quantitative morphologic study. Endocr Pathol 1995; 6(2):115–124.

    PubMed  Google Scholar 

  101. Jugenburg M, Kovacs K, Jungenburg I, Scheithauer BW. Angiogen-esis in endocrine neoplasms. Endocr Pathol 1997;8(4):259–272.

    PubMed  Google Scholar 

  102. Kontogeorgos G, Scheithauer BW, Horvath E, Kovacs K, Lloyd RV, Smyth HS, et al. Double adenomas of the pituitary: a clinicopathologic study of 11 tumors. Neurosurgery 1992;31:840–849.

    PubMed  CAS  Google Scholar 

  103. Wynne AG, Scheithauer BW, Young W, Kovacs K, Ebersold M. Coexisting prolactinoma and corticotropinoma: a case report with reference to the relationship of corticotropin and prolactin excess. Neurosurgery 1992;30:919–923.

    PubMed  CAS  Google Scholar 

  104. Costello RT. Subclinical adenoma of pituitary gland. Am J Pathol 1936;12:205–216.

    PubMed  CAS  Google Scholar 

  105. McComb DJ, Ryan N, Horvath E, Kovacs K. Subclinical adenomas of the human pituitary: new light on old problems. Arch Pathol Lab Med 1983;107:488–491.

    PubMed  CAS  Google Scholar 

  106. Kontogeorgos G, Kovacs K, Horvath E, Scheithauer BW. Multiple adenoma of the pituitary gland. A retrospective autopsy study with clinical implications. J Neurosurg 1991;74:243–247.

    PubMed  CAS  Google Scholar 

  107. Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K. Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 1981;304:156–158.

    PubMed  CAS  Google Scholar 

  108. Kane LA, Leinung MG, Scheithauer BW, Bergstralh EJ, Laws ER Jr, Groover RV, et al. Pituitary adenomas in childhood and adolescence. J Clin Endocrinol Metab 1994;79(4): 1135–1140.

    PubMed  CAS  Google Scholar 

  109. Partington MD, Davis DH, Laws ER Jr, Scheithauer B W. Pituitary adenomas in childhood and adolescence: results of transsphenoidal surgery. J Neurosurg 1994;80:209–216.

    PubMed  CAS  Google Scholar 

  110. Leinung MC, Kane LA, Scheithauer BW, Carpenter PC, Laws ER Jr, Zimmerman D. Long-term treatment of Cushing’s disease in childhood. J Clin Endocr Metab 1995;80:2475–2479.

    PubMed  CAS  Google Scholar 

  111. Mindermann T, Wilson CB. Pediatric pituitary adenomas. Neurosurgery 1995;36:259–269.

    PubMed  CAS  Google Scholar 

  112. Lloyd RV, Chandler WF, Kovacs K, Ryan N. Ectopic pituitary adenomas with normal anterior pituitary glands. Am J Surg Pathol 1986;10;546–552.

    PubMed  CAS  Google Scholar 

  113. Kleinschmidt-DeMasters BK, Winston KR, Rubinstein D, Samuels MA. Ectopic pituitary adenoma of the third ventricle. Case report. J Neurosurg 1990;72:139–142.

    PubMed  CAS  Google Scholar 

  114. Kikuchi K, Kowada M, Sasaki J, Sageshima M. Large pituitary adenoma of the sphenoid sinus and the nasopharynx: report of a case with ultrastructural evaluations. Surg Neurol 1994;42: 330–334.

    PubMed  CAS  Google Scholar 

  115. Takahata T, Katayama Y, Tsubokawa T, Oshima H, Yoshino A. Ectopic pituitary adenoma occurring in the interpeduncular cistern. J Neurosurg 1995;83:1092–1094.

    PubMed  CAS  Google Scholar 

  116. Palmer PE, Bogojavlensky S, Bhan AK, Scully RE. Prolactinoma in wall of ovarian dermoid cyst with hyperprolactinemia. Obstet Gynecol 1990;75:540–543.

    PubMed  CAS  Google Scholar 

  117. Hardy J. Transsphenoidal microsurgery of the normal and pathological pituitary. Clin Neurosurg 1969;16:185–217.

    PubMed  CAS  Google Scholar 

  118. Lloyd RV, Scheithauer BW, Kovacs K, Roche PC. The immu-nophenotype of pituitary adenomas. Endocr Pathol 1996;7:145–150.

    PubMed  Google Scholar 

  119. Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 1986;65:733–744.

    PubMed  CAS  Google Scholar 

  120. Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM. The occurrence of dural invasion in pituitary adenomas. J Neurosurg 1986;4:402–407.

    Google Scholar 

  121. Anniko M, Tribukait B, Wersall J. DNA ploidy and cell phase in human pituitary tumors. Cancer 1984;53:1708–1713.

    PubMed  CAS  Google Scholar 

  122. Levy A, Hall L, Yeudall WA, Lightman SL. p53 gene mutations in pituitary adenomas: rare events. Clin Endocrinol 1994;41: 809–814.

    CAS  Google Scholar 

  123. Laws ER Jr, Scheithauer BW, Carpenter S, Randall RV, Abboud CF. The pathogenesis of acromegaly. Clinical and immunocy-tochemical analysis in 75 patients. J Neurosurg 1984;63:35–38.

    Google Scholar 

  124. Scheithauer BW, Kovacs K, Randall RV, Horvath E, Laws ER Jr. Pathology of excessive production of growth hormone. J Clin Endocrinol Metab 1986;15:655–681.

    CAS  Google Scholar 

  125. Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 1988;9:357–373.

    PubMed  CAS  Google Scholar 

  126. Horvath E, Scheithauer BW, Kovacs K, Randall RV, Laws ER Jr, Thorner MO, et al. Pituitary adenomas producing growth hormone, prolactin, and one or more glycoprotein hormones: a histologic, immunohistochemical, and ultrastructural study of four surgically removed tumors. Ultrastruct Pathol 1983;5:171–183.

    PubMed  CAS  Google Scholar 

  127. Scheithauer BW, Horvath E, Kovacs K, Laws ER Jr, Randall RV, Ryan N. Plurihormonal pituitary adenomas. Semin Diagn Pathol 1986;3:69–82.

    PubMed  CAS  Google Scholar 

  128. Horvath E, Kovacs K. Ultrastructural diagnosis of human pituitary adenomas. Microsc Res Tech 1992;20:107–135.

    PubMed  CAS  Google Scholar 

  129. Horvath E, Kovacs K. Ultrastructural diagnosis of pituitary adenomas and hyperplasias. In: Lloyd RV, ed. Surgical pathology of the Pituitary Gland. WB Saunders, Philadelphia, 1993, pp. 52–84.

    Google Scholar 

  130. Neuman PE, Goldman JE, Horoupian DS, Hess MA. Fibrous bodies in growth hormone-secreting adenomas contain cytokeratin filaments. Arch Pathol Lab Med 1985;109:505–508.

    Google Scholar 

  131. Robert F. Electron microscopy of human pituitary tumors. In: Tindall GT, Collins WF, eds. Clinical Management of Pituitary Disorders. Raven, New York, 1979, pp. 113–131.

    Google Scholar 

  132. Horvath E, Kovacs K, Scheithauer BW, Lloyd RV, Smyth HS. Pituitary adenoma with neuronal choristoma (PANCH): composite lesion or lineage infidelity? Ultrastruct Pathol 1994;18:565–574.

    PubMed  CAS  Google Scholar 

  133. Horvath E, Kovacs K. Pathology of prolactin cell adenomas of the human pituitary. Semin Diagn Pathol 1986;3:4–17.

    PubMed  CAS  Google Scholar 

  134. Randall RV, Scheithauer BW, Laws ER Jr, Abboud CF, Ebersold MJ, Kao PC. Pituitary adenomas associated with hyperpro-lactinemia: a clinical and immunohistochemical study of 97 patients operated on transsphenoidal. Mayo Clin Proc 1985; 60:753–762.

    PubMed  CAS  Google Scholar 

  135. Annegers JF, Coulam CB, Abboud CF, Laws ER Jr, Kurland LT. Pituitary adenoma in Olmstead County, Minnesota, 1935–1977. A report of an increasing incidence of diagnosis in women of child-bearing age. Mayo Clin Proc 1978;53:641–643.

    PubMed  CAS  Google Scholar 

  136. Calle-Rodrigue R, Giannini C, Scheithauer BW, Lloyd RV, Kovacs K, Stefaneanu L, et al. Prolactinomas in male and female patients: a comparative clinicopathologic study. Mayo Clin Proc 1998; 73:1046–1052.

    PubMed  CAS  Google Scholar 

  137. Rilliet B, Mohr G, Robert F, Hardy J. Calcification in pituitary adenomas. Surg Neurol 1981;15:249–255.

    PubMed  CAS  Google Scholar 

  138. Webster J, Peters JR, John R, Smith J, Chan V, Hall R, et al. Pituitary stone: two cases of densely calcified thyrotrophin-secret-ing pituitary adenoma. Clin Endocrinol (Oxford) 1984;40: 137–143.

    Google Scholar 

  139. Hinton DR, Polk RK, Linse KD, Weiss MH, Kovacs K, Garner JA. Characterization of spherical amyloid protein from a prolactin-producing pituitary adenoma. Acta Neuropathol 1997;93:43–49.

    PubMed  CAS  Google Scholar 

  140. Landolt AM, Kleihues P, Heitz PU. Amyloid deposits in pituitary adenomas. Differentiation of two types. Arch Pathol Lab Med 1987;111:453–458.

    PubMed  CAS  Google Scholar 

  141. Scheithauer BW, Horvath E, Kovacs K, Lloyd RV, Stefaneanu L, Buchfelder M, et al. Prolactin-producing pituitary adenoma and carcinoma with neuronal components—a metaplastic lesion. Pituitary 1999;1:197–206.

    PubMed  CAS  Google Scholar 

  142. Corenblum B, Sirek AM, Horvath E, Kovacs K, Ezrin C. Human mixed somatotrophic and lactotrophic pituitary adenomas. J Clin Endocrinal Metab 1976;42:857–863.

    CAS  Google Scholar 

  143. Li J, Stefaneanu L, Kovacs K, Horvath E, Smyth HS. Growth hormone (GH) and prolactin (PRL) gene expression and immu noreactivity in GH- and PRL-producing human pituitary adenomas. Virchows Arch Pathol Anat 1993;422:193–201.

    CAS  Google Scholar 

  144. Horvath E, Kovacs K, Singer W, Smyth HS, Killinger DW, Ezrin C. Mammosomatotroph cell adenoma of the human pituitary: a morphologic entity. Virchows Arch Pathol Anat 1983;398:277–289.

    CAS  Google Scholar 

  145. Horvath E, Kovacs K, Singer W, Smyth HS, Killinger DW, Ezrin C, et al. Acidophil stem cell adenoma of the human pituitary: clinico-pathological analysis of 15 cases. Cancer 1981;47:761–771.

    PubMed  CAS  Google Scholar 

  146. Robert F, Hardy J. Human corticotroph cell adenomas. Semin Diagn Pathol 1986;3:34–41.

    PubMed  CAS  Google Scholar 

  147. McNicol AM. Patterns of corticotropic cells in the adult human pituitary in Cushing’s disease. Diagn Histopathol 1981;4:335–341.

    PubMed  CAS  Google Scholar 

  148. Lloyd RV, Chandler WF, McKeever PE, Schteingart DE. The spectrum of ACTH-producing pituitary lesions. Am J Surg Pathol 1986;10:618–626.

    PubMed  CAS  Google Scholar 

  149. Berg KK, Scheithauer BW, Felix I, Kovacs K, Horvath E, Klee GG, et al. Pituitary adenomas that produce adrenocorticotropic hormone and α-subunit; clinicopathological, immuno-histochemi-cal, ultrastructural, and immunoelectron microscopic studies in nine cases. Neurosurgery 1990;26:357–403.

    Google Scholar 

  150. Neuman PE, Horoupian DS, Goldman JE, Hess MA. Cytoplasmic filaments of Crooke’s hyaline change belong to the cytokeratin class. An immunocytochemical and ultrastructural study. Am J Pathol 1984;116:214–222.

    Google Scholar 

  151. Crooke A. A change in the basophil cells of the pituitary gland common to conditions which exhibit the syndrome attributed to basophil adenoma. J Pathol Bacteriol 1935;41:339–349.

    Google Scholar 

  152. Felix IA, Horvath E, Kovacs K. Massive Crooke’s hyalinization in corticotroph cell adenoma of the human pituitary. A histological, immunocytochemical, and electron microscopic study of three cases. Acta Neurochirurg (Wien) 1982;58:235–243.

    Google Scholar 

  153. Horvath E, Kovacs K, Josse R. Pituitary corticotroph cell adenoma with marked abundance of microfilaments. Ultrastruct Pathol 1983;5:249–255.

    PubMed  CAS  Google Scholar 

  154. Jaap AJ, Scheithauer BW, Kovacs K, Horvath E, Lloyd RV, Meyer FB, et al. A clinicopathologic study of silent corticotroph adenoma. Endocr Pathol 1998;9:393–394.

    Google Scholar 

  155. Bilbao J, Kovacs K, Horvath E, Higgins HP, Horsey WJ. Pituitary melanocorticotrophinoma with amyloid deposition. Can J Neurol Sci 1975;2:199–202.

    PubMed  CAS  Google Scholar 

  156. Gharib H, Carpenter PC, Scheithauer BW, Service FJ. The spectrum of inappropriate pituitary thyrotropin secretion associated with hyperthyroidism. Mayo Clin Proc 1982;57:556–563.

    PubMed  CAS  Google Scholar 

  157. Fatourechi V, Gharib H, Scheithauer BW, et al. Pituitary thyrotropic adenoma associated with congenital hypothyroidism. Am J Med 1984;76:725–728.

    PubMed  CAS  Google Scholar 

  158. Girod C, Trouillas J, Claustrat B. The human thyrotropic adenoma: pathologic diagnosis in five cases and critical review of the literature. Semin Diagn Pathol 1986;3:58–68.

    PubMed  CAS  Google Scholar 

  159. Wajchenberg BL, Tsanaclis AMC, Marino R Jr. TSH-containing pituitary adenoma associated with primary hypothyroidism manifested by amenorrhea and galactorrhea. Acta Endocrinol (Kbh) 1984;106:61–66.

    CAS  Google Scholar 

  160. Gesundheit N, Petrick PA, Nissim M, Dahlberg PA, Doppman JL, Emerson CH, et al. Thyrotropin-secreting pituitary adenomas: Clinical and biochemical heterogeneity. Case reports and follow-up of nine patients. Ann Intern Med 1989;111:827–835.

    PubMed  CAS  Google Scholar 

  161. Kuzuya N, Inoue K, Ishibashi M, et al. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, a-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells. J Clin Endocrinol Metab 1990;71:1103–1111.

    PubMed  CAS  Google Scholar 

  162. Wynne AG, Gharib H, Scheithauer BW, et al. Hyperthyroidism due to inappropriate secretion of thyrotropin in 10 patients. Am J Med 1992;92:15–24.

    PubMed  CAS  Google Scholar 

  163. Pernicone PJ, Scheithauer BW. Invasive pituitary adenomas and pituitary carcinomas. In: Lloyd RV, ed. Surgical Pathology of the Pituitary Gland. Saunders, Philadelphia, Major Probl Pathol 1993, pp. 121–136.

    Google Scholar 

  164. Friend KE, Chiou YK, Laws ER Jr, Lopes MB, Shupnik MA. Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endocrinol Metab 1993;77; 1281–1286.

    PubMed  CAS  Google Scholar 

  165. Sanno N, Teramoto A, Matsuno A, Osamura Y. Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Arch Pathol Lab Med 1996;120:73–77.

    PubMed  CAS  Google Scholar 

  166. Yamada S, Takahashi M, Hara M, Hattori A, Sano T, Ozawa Y, et al. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method. Clin Endocrinol 1996;45:263–272.

    CAS  Google Scholar 

  167. Sano T, Kovacs K, Asa SL, Smyth HS. Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases. Virchows Arch Pathol Anat 1990;417:351–367.

    Google Scholar 

  168. Horvath E, Kovacs K. Gonadotroph adenomas of the human pituitary: sex-related fine structural dichotomy. A histologic, immunohistochemical and electron microscopic study of 30 tumors. Am J Pathol 1984;117:429–440.

    PubMed  CAS  Google Scholar 

  169. Trouillas J, Girod C, Sassolas G, Claustrat B. The human gonadotropic adenoma: pathologic diagnosis and hormonal correlations in 26 tumors. Semin Diagn Pathol 1986;3:42–57.

    PubMed  CAS  Google Scholar 

  170. Young WF Jr, Scheithauer BW, Kovacs KT, Horvath E, Davis DH, Randall RV. Gonadotroph adenoma of the pituitary gland: a clinico-pathologic analysis of 100 cases. Mayo Clin Proc 1996;71:649–656.

    PubMed  Google Scholar 

  171. Kontogeorgos G, Horvath E, Kovacs K. Sex-linked ultrastructural dichotomy of gonadotroph adenomas of the human pituitary: an electron microscopic analysis of 145 tumors. Ultrastruct Pathol 1990;14:475–482.

    PubMed  CAS  Google Scholar 

  172. Kovacs K, Horvath E, Ryan N, Ezrin C. Null cell adenoma of the human pituitary. Virchows Arch Pathol Anat 1980;387:165–174.

    PubMed  CAS  Google Scholar 

  173. Kovacs K, Asa SL, Horvath E, Ryan N, Singer W, Killinger DW, et al. Null cell adenomas of the pituitary: attempts to resolve their cytogenesis. In: Lechago J, Kameya T, eds. Endocrine Pathology Update, Field and Wood, Philadelphia, 1990, pp. 17–31.

    Google Scholar 

  174. Saeger W, Gunzl H, Meyer M, Schulze C, Ludecke DK. Immuno-histological studies on clinically silent pituitary adenomas. Endocr Pathol 1990;1:37–44.

    Google Scholar 

  175. Kontogeorgos G, Kovacs K, Horvath E, Scheithauer BW. Null cell adenomas, oncocytomas, and gonadotroph adenomas of the human pituitary: an immunocytochemical and ultrastructural analysis of 300 cases. Endocrinol Pathol 1993;4:20–27.

    Google Scholar 

  176. Asa SL, Gerrie B, Singer W, Horvath E, Kovacs K, Smyth HS. Gonadotropin secretion in vitro by human pituitary null cell adenomas and oncocytomas. J Clin Endocrinol Metab 1986;62:1011–1019.

    PubMed  CAS  Google Scholar 

  177. Asa SL, Cheng Z, Ramyar L, Singer W, Kovacs K, Smyth HS, et al. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology. J Clin Endocrinol Metab 1992;74:1128–1134.

    PubMed  CAS  Google Scholar 

  178. Jamieson JL, Klibanski A, Black McL, et al. Glycoprotein hormone genes are expressed in clinically non-functioning pituitary adenomas. J Clin Invest 1987;80:1472–1478.

    Google Scholar 

  179. Sakurai T, Seoh H, Yamamoto N, et al. Detection of mRNA of prolactin and ACTH in clinically non-functioning adenomas. J Neurosurg 1988;69:653–659.

    PubMed  CAS  Google Scholar 

  180. Matsuno A, Teramoto A, Takekoshi S, et al. HGH, PRL and ACTH gene expression in clinically non-functioning adenomas detected with nonisotopic in situ hybridization method. Endocr Pathol 1995;6:13–20.

    PubMed  CAS  Google Scholar 

  181. Yamada S, Asa SL Kovacs K. Oncocytomas and null cell adenomas of the human pituitary: morphometric and in vitro functional comparison. Virchows Arch Pathol Anat 1988;413:333–339.

    CAS  Google Scholar 

  182. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W. Silent corticotropic adenomas of the human pituitary gland; a histologic, immunocytologic and ultrastructural study. Am J Pathol 98:617–638, 1980.

    PubMed  CAS  Google Scholar 

  183. Horvath E, Kovacs K, Smyth HS, Killinger DW, Scheithauer BW, Randall R, et al. A novel type of pituitary adenoma: morphological features and clinical correlations. J Clin Endocrinol Metab 1988;66:1111–1118.

    PubMed  CAS  Google Scholar 

  184. Lloyd RV, Fields K, Jin L, Horvath E, Kovacs K. Analysis of endocrine active and clinically silent, corticotropic adenomas by in situ hybridization. Am J Pathol 1990;137:479–488.

    PubMed  CAS  Google Scholar 

  185. Nagaya T, Seo H, Kuwayama A, et al. Proopiomelanocortin gene expression in silent corticotroph cell adenoma and Cushing’s disease. J Neurosurg 1990;72:262–267.

    PubMed  CAS  Google Scholar 

  186. Stefaneanu L, Kovacs K, Horvath E, Lloyd RV. In situ hybridization study of pro-opiomelanocortin (POMC) gene expression in human pituitary corticotrophs and their adenomas. Virchows Arch Pathol Anat 1991;419:107–113.

    CAS  Google Scholar 

  187. Asa SL, Kovacs K, Tindall GT, Barrow DL, Horvath E, Vecsei P. Cushing’s disease associated with an intrasellar gangliocytoma producing corticotrophin-releasing factor. Ann Intern Med 1984;101:789–793.

    PubMed  CAS  Google Scholar 

  188. Saeger W, Puchner MJ, Ludecke DK. Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing’s disease. Virchows Arch Pathol Anat 1994;425:93–99.

    CAS  Google Scholar 

  189. Asa SL, Scheithauer BW, Bilbao JM, Horvath E, Ryan N, Kovacs K, et al. A case for hypothalamic acromegaly: a clinicopathologic study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab 1984;58:796–803.

    PubMed  CAS  Google Scholar 

  190. Scheithauer BW, Kovacs K, Randall RV, Horvath E, Okazaki H, Laws ER Jr. Hypothalamic neuronal hamartoma and adeno-hypophseal neuronal choristoma: their association with growth hormone adenoma of the pituitary gland. J Neuropathol Exp Neurol 1983;42:648–663.

    PubMed  CAS  Google Scholar 

  191. Lach B, Rippstein P, Benoit BG, Staines W. Differentiating neuroblastoma of pituitary gland: neuroblastic transformation of epithelial adenoma cells. Case report. J Neurosurg 1996;85:953–960.

    PubMed  CAS  Google Scholar 

  192. Towfighi J, Salam MM, McLendon RE, Powers S, Page RB. Ganglion cell containing tumors of the pituitary gland. Arch Pathol Lab Med 1996;120:369–377.

    PubMed  CAS  Google Scholar 

  193. Levy A, Lightman SL. Growth hormone-releasing hormone transcripts in human pituitary adenomas. J Clin Endocrinol Metab 1992;74:1474–1476.

    PubMed  CAS  Google Scholar 

  194. Thapar K, Kovacs K, Stefaneanu L, Scheithauer BW, Killinger DW, Lloyd RV, et al. Overexpression of the growth hormone-releasing hormone gene in acromegaly associated pituitary tumors: an event associated with neoplastic progression and aggressive behavior. Am J Pathol 1997;151:769–784.

    PubMed  CAS  Google Scholar 

  195. Wakai S, Fukushima T, Teramoto A, Sano K. Pituitary apoplexy: its incidence and clinical significance. J Neurosurg 1981;55: 187–193.

    PubMed  CAS  Google Scholar 

  196. Mohr G, Hardy J. Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol 1982;18:181–189.

    PubMed  CAS  Google Scholar 

  197. Ebersold MJ, Laws ER Jr., Scheithauer, BW, Randall RV. Pituitary apoplexy treated by transsphenoidal surgery: a clinico-pathology and immunocytochemical study. J Neurosurg 1983; 58:315–320.

    PubMed  CAS  Google Scholar 

  198. Bills DC, Meyer FB, Laws ER Jr, Davis DH, Ebersold MJ, Scheithauer BW, et al. A retrospective analysis of pituitary apoplexy. Neurosurgery 1993;33:602–609.

    PubMed  CAS  Google Scholar 

  199. Bonicki W, Kasperlik-Azluska A, Koszewski W, Zgliczynski W, Wislawski J. Pituitary apoplexy: endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas. Acta Neurochirurgica 1993;120:118–122.

    PubMed  CAS  Google Scholar 

  200. Shirataki K, Chihara K, ShibataY, Tamaki N, Matsumoto S, Fujita T. Pituitary apoplexy manifested during a bromocriptine test in a patient with a growth hormone- and prolactin-producing pituitary adenoma. Neurosurg 1988;23:395–398.

    CAS  Google Scholar 

  201. Masago A, Eueda Y, Kanai H, Magal H, Umemura S. Pituitary apoplexy after pituitary function test: a report of two cases and review of the literature [review]. Surg Neurol 1995; 43:158–164.

    PubMed  CAS  Google Scholar 

  202. Reznik Y, Chapon F, Lahlou N, Deboucher N, Mahoudeau J. Pituitary apoplexy of a gonadotroph adenoma following gonado-trophin-releasing hormone agonist therapy for prostatic therapy. J Endocr Invest 1997;20:566–568.

    PubMed  CAS  Google Scholar 

  203. Pernicone PJ, Scheithauer BW, Sebo TJ, Kovacs KT, Horvath E, Young WF, et al. Pituitary carcinoma. A clinicopathologic study of 15 cases. Cancer 1997;79:804–812.

    PubMed  CAS  Google Scholar 

  204. Davis DH, Laws ER Jr., Ilstrup DM, Speed JK, Caruso M, Shaw EG, et al. Results of surgical treatment for growth hormone-secreting pituitary adenomas. J Neurosurg 1993;79:70–75.

    PubMed  CAS  Google Scholar 

  205. Fisher BJ, Gaspar Le, Noone B. Radiation therapy of pituitary adenoma: delayed sequelae. Radiology 1993;187:843–846.

    PubMed  CAS  Google Scholar 

  206. Bliss P, Kerr GR, Gregor A. Incidence of second brain tumours after pituitary irradiation in Edinburgh 1962–1990. Clin Oncol 1994;6:361–363.

    CAS  Google Scholar 

  207. Rauhut F, Stolhe D. Combined surgery and radiotherapy of invasive pituitary adenomas—problems of radiogenic encephalopathy. Acta Neurochir, Suppl 1996;65:37–40.

    CAS  Google Scholar 

  208. Simmons NE, Laws ER Jr. Glioma occurrence after sellar irradiation: case report and review. Neurosurgery 1998;42: 172–178.

    PubMed  CAS  Google Scholar 

  209. Marks LB. Conventional fractionated radiation vs. radiosurgery for selected benign intracranial lesions (arteriovenous malformations, pituitary adenomas, and acoustic neuromas). Review. J Neuro-Oncol 1993;17:223–230.

    CAS  Google Scholar 

  210. Pollock BE, Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results. Acta Neurochir Suppl 1994;62:33–38.

    PubMed  CAS  Google Scholar 

  211. Motti ED, Losa M, Pieralli S, Zecchinelli A, Longobardi B, Giugni E, et al. Stereotactic radiosurgery of pituitary adenomas. Review. Metabolism: Clin Exp 1996;45(8 Suppl 1):111–114.

    CAS  Google Scholar 

  212. Schaardenburg D van, Roelfsema F, Srters AP van, Vielvoye GJ. Bromocriptine therapy for non-functioning pituitary adenoma. Clin Endocrinol 1989;30:475–484.

    Google Scholar 

  213. Ciccarelli E, Camanni F. Diagnosis and drug therapy of prolactinoma. Review Drugs 1996;51:954–965.

    CAS  Google Scholar 

  214. Fahlbusch R, Buchfelder M, Schrell U. Short-term preoperative treatment of acroprolactinomas by dopamine agonists. J Neurosurg 1987;67:807–815.

    PubMed  CAS  Google Scholar 

  215. Pellegrini I, Rasolonjanahary R, Gunz G, Bertrand P, Delivet S, Jedynak CP, Kordon C, Peillon F, Jaquet P, Enjalbert A. Resistance to bromocriptine in prolactinomas. J Clin Endocrinol Metab 1989;69:500–509.

    PubMed  CAS  Google Scholar 

  216. Saeger W, Mohr K, Caselitz J, Ludecke DK. Light and electron microscopical morphometry of pituitary adenomas in hyperpro-lactinemia. Path Res Pract 1986;181:544–550.

    PubMed  CAS  Google Scholar 

  217. Bevan JS, Webster J, Burke CW, Scanlon MF. Dopamine agonists and pituitary tumors shrinkage. Endocr Rev 1992;13:220–240.

    PubMed  CAS  Google Scholar 

  218. Horvath E, Kovacs K, Killinger DW, Gonzalez J, Smyth HS. Diverse ultrastructural response to dopamine agonist medication in human pituitary prolactin cell adenomas. In: Hoshino K, ed. Prolactin Gene Family and Its Receptors. Elsevier, Amsterdam, 1988, pp. 307–311.

    Google Scholar 

  219. Barkan AL, Lloyd RV, Chandler WF, Hatfield MK, Gebarski SS, Kelch RP, et al. Preoperative treatment of acromegaly with long-acting somatostatin analog SM S 201–995: shrinkage of invasive pituitary macroadenomas and improved surgical remission rate. J Clin Endocrinol Metab 1988;67:1040–1048.

    PubMed  CAS  Google Scholar 

  220. Bertherat J, Brue T, Enjalbert A, Gunz G, Rasolonjanahary R, Warnet A, et al. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab 1992;75:540–546.

    PubMed  CAS  Google Scholar 

  221. Chanson P, Weintraub BD, Harris AG. Octreotide therapy for thyroid-stimulating hormone-secreting pituitary adenomas. Ann Intern Med 1993;119;236–240.

    PubMed  CAS  Google Scholar 

  222. Newman CB, Melmed S, Snyder PJ, et al. Safety and efficacy of long term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients—a clinical research center study. J Clin Endocrinol Metab 1995;80:2768–2775.

    PubMed  CAS  Google Scholar 

  223. Lamberts SWJ, van der Lely AJ, de Herder WW, Holland LJ. Octreotide. N Engl J Med 1996;334:246–254.

    PubMed  CAS  Google Scholar 

  224. Thapar K, Kovacs KT, Stefaneanu L, Scheithauer BW, Horvath E, Lloyd RV, et al. Antiproliferative effect of the somatostatin analogue octreotide on growth hormone-producing pituitary tumors: results of a multicenter randomized trial. Mayo Clin Proc 1997; 72:893–900.

    PubMed  CAS  Google Scholar 

  225. Vance ML, Harris AG. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group. Arch Intern Med 1991;151:1573–1578.

    PubMed  CAS  Google Scholar 

  226. Ezzat S, Snyder PJ, Young WF, Boyajy LD, Newman C, Klibanski A, et al. Octreotide treatment of acromegaly: a randomized, multicenter study. Ann Intern Med 1992;117:711–718.

    PubMed  CAS  Google Scholar 

  227. Ezzat S, Horvath E, Harris AG, Kovacs K. Morphologic effects of octreotide on growth hormone-producing pituitary adenomas. J Clin Endocrinol Metab 1994;79:113–118.

    PubMed  CAS  Google Scholar 

  228. Saeger W, Ludecke DK. Pituitary hyperplasia. Definition, light and electron microscopic structures and significance in surgical specimens. Virchows Arch Pathol Anat 1983;399:277–287.

    CAS  Google Scholar 

  229. Horvath E, Kovacs K, Scheithauer BW. Pituitary hyperplasia. Pituitary 1999;1:169–180.

    PubMed  CAS  Google Scholar 

  230. Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, et al. Somatotroph hyperplasia. J Clin Invest 1982; 70:965–977.

    PubMed  CAS  Google Scholar 

  231. Ezzat S, Asa SL, Stefaneanu L, Whittom R, Smyth HS, Horvath E, et al. Somatotroph hyperplasia without pituitary adenoma associated with a long-standing growth hormone-releasing hormone-producing bronchial carcinoid. J Clin Endocrinol Metab 1994; 78:555–560.

    PubMed  CAS  Google Scholar 

  232. Kovacs K, Horvath E, Thorner MO, Rogol AD. Mammosoma-totroph hyperplasia associated with acromegaly and hyperpro-lactinemia in a patient with the McCune-Albright syndrome: a histologic, immunocytologic and ultrastructural study of the surgically removed adenohypophysis. Virchows Arch Pathol Anat 1984;403:77–86.

    CAS  Google Scholar 

  233. Moran A, Asa SL, Kovacs K, et al. Gigantism due to pituitary mammosomatotroph hyperplasia. N Engl J Med 1990;323: 322–326.

    PubMed  CAS  Google Scholar 

  234. Zimmerman D, Young WF Jr, Ebersold MJ, et al. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab 1993;46:216–222.

    Google Scholar 

  235. Scheithauer BW, Carpenter PC, Block B. Ectopic secretion of a growth hormone releasing factor: report of a case of acromegaly with bronchial carcinoid tumor. Am J Med 1984;76:605–616.

    PubMed  CAS  Google Scholar 

  236. Stefaneanu L, Kovacs K, Lloyd R, Scheithauer BW, Sano T, Young W. Pituitary lactotrophs and somatotrophs in pregnancy: a correlative in situ hybridization and immunocytochemical study. J Clin Endocrinol Metab 1992;62:291–296.

    CAS  Google Scholar 

  237. Pioro EP, Scheithauer BW, Laws ER Jr, Randall RV, Kovacs K, Horvath E. Combined thyrotroph and lactotroph cell hyperplasia simulating prolactin-secreting pituitary adenoma in longstanding primarily hypothyroidism. Surg Neurol 1988;29: 218–226.

    PubMed  CAS  Google Scholar 

  238. Scheithauer BW, Kovacs KT, Young WF Jr, Randall RV. The pituitary gland in hypothyroidism. Mayo Clin Proc 1992;67: 22–26.

    PubMed  CAS  Google Scholar 

  239. Scheithauer BW, Kovacs KT, Randall RV, Ryan N. Effects of estrogen upon the human pituitary: a clinicopathologic study. Mayo Clin Proc 1989;64:1077–1084.

    PubMed  CAS  Google Scholar 

  240. Jay V, Kovacs K, Horvath E, Lloyd RV, Smyth HS. Idiopathic prolactin cell hyperplasia of the pituitary mimicking prolactin cell adenoma: a morphological study including immunocytochemis-try, electron microscopy and in situ hybridization. Acta Neuropathol 1991;82:147–151.

    PubMed  CAS  Google Scholar 

  241. Kovacs K, Stefaneanu L, Ezzat S, Smyth HS. Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study. Arch Pathol Lab Med 1994;118:562–565.

    PubMed  CAS  Google Scholar 

  242. Carey RM, Varma SK, Drake CR Jr, Thorner MO, Kovacs K, Rivier J, et al. Ectopic secretion of corticotropin releasing factor as a cause of Cushing’s syndrome: a clinical, morphologic, and biochemical study. N Engl J Med 1984;311:13–20.

    PubMed  CAS  Google Scholar 

  243. Schteingart DE, Lloyd RV, Akil H, et al. Cushing’s syndrome secondary to ectopic corticotropin-releasing hormone-adreno-corticotropin secretion. J Clin Endocrinol Metab 1986;63: 770–775.

    PubMed  CAS  Google Scholar 

  244. Scheithauer BW, Kovacs K, Randall RV. The pituitary gland in untreated Addison’s disease. A histologic and immunocytologic study of 18 adenohypophyses. Arch Pathol Lab Med 1983; 107: 484–487.

    PubMed  CAS  Google Scholar 

  245. Saeger W, Geisler F, Lüdecke DK. Pituitary pathology in Cushing’ s disease. Pathol Res Pract 1988;183:592–595.

    PubMed  CAS  Google Scholar 

  246. Young WF Jr, Scheithauer BW, Gharib H, Laws ER Jr, Carpenter PC. Cushing’s syndrome due to primary multinodular corticotrope hyperplasia. Mayo Clin Proc 1988;63:256–262.

    PubMed  Google Scholar 

  247. Kovacs K, Stefaneanu L, Horvath E, Buchfelder M, Fahlbusch R, Althoff PH, et al. Pituitary corticotroph adenoma in a woman with long-standing Addison’s disease: a histologic, immunocytochemical, electron microscopic and in situ hybridization study. Endocr Pathol 1996;7:91–97.

    PubMed  Google Scholar 

  248. Khalil A, Kovacs K, Sima AAF, Burrow GN, Horvath E. Pituitary thyrotroph hyperplasia mimicking prolactin-secreting adenoma. J Endocrinol Invest 1984;7:399–404.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Bernd W. Scheithauer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eva Horvath PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ricardo V. Lloyd MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kalman Kovacs MD, PhD, DSc
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Neurosurgery, Department of Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada

    Kamal Thapar MD, PhD

  2. Department of Pathology and Laboratory Medicine, St. Michael’s Hospital, Toronto, Ontario, Canada

    Kalman Kovacs MD, PhD

  3. Department of Pathology, Mayo Clinic, Rochester, MN, USA

    Bernd W. Scheithauer MD  & Ricardo V. Lloyd MD, PhD  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Scheithauer, B.W., Horvath, E., Lloyd, R.V., Kovacs, K. (2001). Pathology of Pituitary Adenomas and Pituitary Hyperplasia. In: Thapar, K., Kovacs, K., Scheithauer, B.W., Lloyd, R.V. (eds) Diagnosis and Management of Pituitary Tumors. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-217-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-217-3_7

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9693-2

  • Online ISBN: 978-1-59259-217-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation